New Jersey 2024-2025 Regular Session

New Jersey Senate Bill SJR25

Introduced
1/9/24  

Caption

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

Impact

If enacted, SJR25 would significantly influence state healthcare practices by standardizing procedures for administering opioid antidotes in hospital settings. The proposed commission will evaluate existing practices in New Jersey and other states to ensure that hospitals adhere to a consistent and effective protocol upon the release of patients after opioid overdose treatment. It aims to enhance patient care and recovery outcomes, ultimately addressing the broader opioid crisis at the state level.

Summary

Senate Joint Resolution No. 25 (SJR25) is aimed at addressing the critical issue of opioid overdose and its aftermath by establishing a temporary Commission on Opioid Antidote Administration and Aftercare. The primary goal of this commission is to study and evaluate the various procedures utilized by hospitals when a patient is discharged after receiving naloxone or other opioid antidotes. It seeks to unify the protocols and recommend best practices that promote the recovery of patients recovering from substance use disorders.

Contention

There may be points of contention surrounding the bill regarding the selection of commission members and the impact of the recommended protocols on hospital operations. The commission will consist of 15 members, including state health officials and representatives from healthcare organizations, as well as public members with relevant expertise. Ensuring diverse representation is crucial for addressing the complexities of opioid treatment and aftercare effectively. Critics may argue about the adequacy of the processes involved in selecting these members or the potential bureaucratic implications of implementing standardized procedures across various healthcare facilities.

Companion Bills

NJ SJR31

Carry Over Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

Previously Filed As

NJ SJR31

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

NJ A277

Authorizes public libraries to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by librarian or other trained library employee.

NJ A1170

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ S186

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ S3678

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ A5580

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ A3749

Establishes position of Statewide Opioid Antidote Coordinator.

NJ S2301

Establishes position of Statewide Opioid Antidote Coordinator.

NJ A284

Establishes position of Statewide Opioid Antidote Coordinator.

NJ S2017

Establishes Statewide Opioid Antidote Coordinator position; appropriates funds.

Similar Bills

CA AB870

Prisoners: mental health treatment.

NJ SJR31

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

CA AB1058

Medi-Cal: specialty mental health services and substance use disorder treatment.

CA SB46

Controlled substances: treatment.

CA AB1750

Controlled substances: treatment.

CA SB889

California Department of Tax and Fee Administration: earnings withholding orders: settlement agreements: excise taxes.

CA SB904

Controlled substances: treatment.

CA AB1998

Opioids: safe prescribing policy.